Complete Filing Data
Xenon Pharmaceuticals Inc. reported Net Income Loss of -$345.91 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Xenon Pharmaceuticals Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$345.9M | -$234.3M | -$182.4M | -$125.4M | -$78.9M | -$28.8M | -$41.6M | -$34.5M | -$30.7M | -$23.0M | -$15.8M | $13.0M | $12.0M | -$4.3M |
| Revenue * | $7.5M | $0.00 | $0.00 | $9.4M | $18.4M | $32.2M | $6.8M | $311.0K | $1.8M | $15.6M | $28.4M | $27.4M | $14.3M | |
| Operating Income Loss | -$373.1M | -$279.3M | -$214.1M | -$129.1M | -$79.0M | -$31.3M | -$42.8M | -$38.0M | -$32.6M | -$24.8M | -$9.4M | $11.1M | $9.7M | -$3.2M |
| Research And Development Expense | $300.9M | $210.4M | $167.5M | $105.8M | $75.5M | $50.5M | $38.8M | $23.6M | $25.6M | $19.8M | $15.2M | $11.8M | $12.3M | $10.5M |
| Operating Expenses | $380.6M | $279.3M | $214.1M | $138.6M | $97.4M | $63.5M | $49.6M | $38.0M | $32.9M | $26.6M | $24.9M | $17.3M | $17.6M | $17.5M |
| General And Administrative Expense | $79.6M | $68.9M | $46.5M | $32.8M | $22.0M | $12.9M | $10.8M | $8.4M | $7.3M | $6.8M | $9.8M | $5.5M | $5.3M | $7.0M |
| Net Income Loss Available To Common Stockholders Basic | -$234.3M | -$182.4M | -$124.9M | -$77.1M | -$28.0M | -$40.0M | -$31.6M | -$30.7M | -$15.8M | $13.0M | $3.8M | -$4.3M | ||
| Income Tax Expense Benefit | $1.0M | -$4.1M | -$292.0K | $118.0K | -$6.0K | -$257.0K | -$23.0K | -$24.0K | ||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$344.9M | -$238.4M | -$182.7M | -$125.3M | -$78.9M | -$29.1M | -$41.6M | -$34.5M | ||||||
| Comprehensive Income Net Of Tax | -$344.0M | -$235.9M | -$179.5M | -$127.4M | -$78.9M | -$28.8M | -$23.0M | -$15.8M | $9.5M | $10.8M | -$4.0M | |||
| Net Income Loss Available To Preferred Stockholders Basic | $437.0K | $1.8M | $824.0K | $1.6M | $2.9M | |||||||||
| Deferred Income Tax Expense Benefit | -$3.2M | -$8.9M | -$292.0K | -$44.0K | $58.0K | -$285.0K | -$133.0K | -$105.0K | ||||||
| Nonoperating Income Expense | $28.2M | $40.9M | $31.4M | $3.9M | $105.0K | $2.2M | ||||||||
| Deferred Income Tax Assets Net | $12.9M | $9.7M | $802.0K | $509.0K | $465.0K | $523.0K | $238.0K | |||||||
| Royalty Revenue | $2.0K | $36.0K | $4.0K | $4.0K | $4.0K | $8.0K | ||||||||
| Other Comprehensive Income Loss Net Of Tax | $1.9M | -$1.5M | $2.9M | -$2.0M | ||||||||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $1.9M | -$1.5M | $2.9M | -$2.0M | ||||||||||
| Interest Expense | $484.0K | $1.4M | $1.4M | $64.0K | $93.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q4 2016 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 | Q2 2013 | Q1 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$90.9M | -$84.7M | -$65.0M | -$62.8M | -$57.9M | -$47.9M | -$48.5M | -$47.5M | -$41.7M | -$37.2M | -$31.2M | -$19.7M | -$15.4M | -$22.1M | -$15.8M | -$8.9M | -$175.0K | -$7.5M | -$8.9M | -$10.0M | -$11.3M | -$14.4M | -$7.8M | -$3.8M | -$8.1M | -$7.7M | -$7.4M | -$7.5M | -$6.0M | -$7.7M | -$6.0M | -$3.3M | -$3.9M | -$3.8M | $1.2M | -$9.2M | $9.2M | $1.2M | $1.4M | $6.4M | ||||
| Revenue * | $0.00 | $0.00 | $7.5M | $0.00 | $0.00 | $0.00 | $132.0K | $536.0K | $8.8M | $8.1M | $2.2M | $4.4M | $6.6M | $13.4M | $7.1M | $3.5M | $16.0K | $264.0K | $15.0K | $16.0K | $376.0K | $413.0K | $413.0K | $601.0K | $3.2M | $4.3M | $4.0M | $4.0M | $4.9M | $13.2M | $5.3M | $5.0M | $5.6M | $10.8M | $5.6M | $5.4M | ||||||||
| Operating Income Loss | -$96.3M | -$94.2M | -$72.7M | -$73.7M | -$69.1M | -$59.0M | -$55.7M | -$55.6M | -$49.1M | -$38.1M | -$30.3M | -$17.4M | -$15.6M | -$22.5M | -$16.1M | -$9.7M | -$646.0K | -$8.0M | -$9.0M | -$10.5M | -$11.8M | -$14.2M | -$7.6M | -$7.8M | -$8.1M | -$8.6M | -$7.9M | -$8.0M | -$5.5M | -$7.3M | -$6.4M | -$5.7M | -$2.6M | -$820.0K | $199.0K | -$6.1M | $35.0K | $8.7M | $1.4M | $1.0M | $2.0M | $6.5M | -$770.0K | $1.9M |
| Research And Development Expense | $77.1M | $75.0M | $61.2M | $57.0M | $49.7M | $44.3M | $42.9M | $44.0M | $39.5M | $29.4M | $22.1M | $19.4M | $18.9M | $18.4M | $16.3M | $13.0M | $10.7M | $11.8M | $9.8M | $8.2M | $9.1M | $6.2M | $5.4M | $5.6M | $7.2M | $6.1M | $5.9M | $6.0M | $5.1M | $4.4M | $3.8M | $3.7M | $3.4M | $3.2M | $2.6M | $2.5M | $2.6M | |||||||
| Operating Expenses | $96.3M | $94.2M | $80.2M | $73.7M | $69.1M | $59.0M | $55.7M | $55.6M | $49.1M | $38.3M | $30.9M | $26.1M | $23.7M | $24.7M | $20.4M | $16.3M | $14.0M | $15.1M | $12.5M | $10.5M | $11.8M | $14.2M | $7.6M | $7.8M | $8.9M | $7.9M | $8.0M | $7.7M | $6.8M | $6.3M | $5.1M | $3.8M | $10.1M | $4.5M | $3.9M | $4.0M | $4.3M | |||||||
| General And Administrative Expense | $19.3M | $19.2M | $19.0M | $16.7M | $19.4M | $14.8M | $12.8M | $11.6M | $9.5M | $8.8M | $8.7M | $6.8M | $4.8M | $6.3M | $4.1M | $3.2M | $3.3M | $3.3M | $2.7M | $2.3M | $2.6M | $1.9M | $2.2M | $2.2M | $1.7M | $1.8M | $2.1M | $1.8M | $1.7M | $1.9M | $1.3M | $178.0K | $6.7M | $1.3M | $1.2M | $1.4M | $1.7M | |||||||
| Net Income Loss Available To Common Stockholders Basic | -$48.5M | -$47.5M | -$41.7M | -$37.2M | -$31.2M | -$19.4M | -$15.1M | -$21.6M | -$15.3M | -$8.6M | -$170.0K | -$7.3M | -$8.5M | -$9.6M | -$10.9M | -$12.8M | -$6.5M | -$3.7M | -$7.7M | -$7.4M | -$7.5M | -$3.9M | -$3.8M | $1.2M | -$9.2M | $1.2M | $3.6M | $0.00 | $2.5M | $1.3M | ||||||||||||||
| Income Tax Expense Benefit | $677.0K | -$626.0K | $427.0K | -$320.0K | -$333.0K | $412.0K | -$157.0K | -$220.0K | $290.0K | -$587.0K | -$40.0K | -$394.0K | -$205.0K | -$217.0K | -$68.0K | -$203.0K | -$39.0K | -$1.0K | $5.0K | -$29.0K | $37.0K | -$8.0K | -$8.0K | $12.0K | ||||||||||||||||||||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$90.2M | -$85.3M | -$64.6M | -$63.1M | -$58.3M | -$47.5M | -$48.6M | -$47.7M | -$41.4M | -$37.7M | -$31.2M | -$20.1M | -$15.7M | -$22.3M | -$15.8M | -$9.1M | -$214.0K | -$7.5M | -$8.9M | -$10.0M | -$11.3M | -$14.4M | -$7.8M | -$3.7M | ||||||||||||||||||||
| Comprehensive Income Net Of Tax | -$90.5M | -$83.8M | -$64.3M | -$59.2M | -$58.4M | -$49.6M | -$48.1M | -$48.9M | -$40.5M | -$39.1M | -$31.2M | -$19.7M | -$15.4M | -$3.8M | $1.2M | -$4.2M | $7.7M | $2.1M | $464.0K | $6.7M | ||||||||||||||||||||||||
| Net Income Loss Available To Preferred Stockholders Basic | $0.00 | $299.0K | $362.0K | $521.0K | $423.0K | $250.0K | $5.0K | $222.0K | $336.0K | $380.0K | $430.0K | $1.6M | $1.3M | $33.0K | ||||||||||||||||||||||||||||||
| Deferred Income Tax Expense Benefit | -$1.2M | $403.0K | $288.0K | $258.0K | $9.0K | $52.0K | $33.0K | -$37.0K | ||||||||||||||||||||||||||||||||||||
| Nonoperating Income Expense | $6.1M | $8.9M | $8.1M | $10.6M | $10.8M | $11.5M | $7.1M | $7.9M | $7.6M | $391.0K | -$883.0K | -$2.7M | -$52.0K | |||||||||||||||||||||||||||||||
| Deferred Income Tax Assets Net | $11.8M | $11.0M | $10.9M | $1.1M | $733.0K | $400.0K | $601.0K | $445.0K | $221.0K | $514.0K | $311.0K | $207.0K | $811.0K | $544.0K | $514.0K | $478.0K | $290.0K | |||||||||||||||||||||||||||
| Royalty Revenue | $1.0K | $1.0K | $1.0K | $32.0K | $1.0K | $2.0K | $1.0K | $2.0K | $2.0K | |||||||||||||||||||||||||||||||||||
| Other Comprehensive Income Loss Net Of Tax | $364.0K | $949.0K | $776.0K | $3.5M | -$443.0K | -$1.7M | $346.0K | -$1.5M | $1.2M | -$2.0M | ||||||||||||||||||||||||||||||||||
| Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax | $364.0K | $949.0K | $776.0K | $3.5M | -$443.0K | -$1.7M | $346.0K | -$1.5M | $1.2M | -$2.0M | $0.00 | $0.00 | ||||||||||||||||||||||||||||||||
| Interest Expense | $154.0K | $330.0K | $363.0K | $365.0K | $358.0K | $678.0K | $200.0K | $159.0K | $15.0K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $581.8M | $754.9M | $927.9M | $721.5M | $550.0M | $171.4M | $92.0M | $103.3M | $35.9M | $63.9M | $61.0M | $72.8M | -$78.4M | -$89.9M | -$86.3M |
| Cash And Cash Equivalents At Carrying Value | $199.2M | $142.7M | $148.6M | $57.2M | $175.7M | $45.0M | $24.8M | $67.8M | $17.1M | $58.7M | $72.0M | $38.0M | $60.2M | $13.9M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $199.2M | $142.7M | $148.6M | $57.2M | $175.7M | $45.0M | $24.8M | $67.8M | $20.5M | ||||||
| Retained Earnings Accumulated Deficit | -$1.25B | -$899.5M | -$665.1M | -$482.7M | -$357.4M | -$278.5M | -$249.7M | -$207.9M | -$173.4M | -$142.7M | -$119.7M | -$103.7M | -$116.8M | ||
| Property Plant And Equipment Net | $8.7M | $10.3M | $9.7M | $6.5M | $4.5M | $3.6M | $1.7M | $991.0K | $1.1M | $1.4M | $2.0M | $2.5M | $1.9M | ||
| Prepaid Expense And Other Assets Current | $10.4M | $6.9M | $6.0M | $7.2M | $4.5M | $3.0M | $2.7M | $1.9M | $716.0K | $1.3M | $1.9M | $686.0K | $153.0K | ||
| Liabilities And Stockholders Equity | $633.2M | $798.1M | $964.8M | $754.1M | $572.0M | $189.2M | $147.7M | $122.4M | $46.1M | $67.5M | $63.9M | $87.4M | $54.5M | ||
| Liabilities | $51.4M | $43.2M | $36.9M | $32.6M | $22.0M | $17.8M | $55.7M | $19.1M | $10.2M | $3.6M | $2.9M | $14.6M | $30.4M | ||
| Common Stock Value | $1.60B | $1.46B | $1.44B | $1.07B | $783.2M | $397.7M | $294.2M | $265.9M | $173.8M | $173.2M | $148.6M | $147.2M | $6.1M | ||
| Assets Current | $560.6M | $635.3M | $645.0M | $600.3M | $559.0M | $181.8M | $144.9M | $121.3M | $44.8M | $65.7M | $60.9M | $84.9M | $49.9M | ||
| Assets | $633.2M | $798.1M | $964.8M | $754.1M | $572.0M | $189.2M | $147.7M | $122.4M | $46.1M | $67.5M | $63.9M | $87.4M | $54.5M | ||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $335.0K | -$1.6M | -$77.0K | -$3.0M | -$990.0K | -$990.0K | -$990.0K | -$990.0K | -$990.0K | -$990.0K | -$990.0K | -$990.0K | $2.5M | ||
| Accounts Payable And Accrued Liabilities Current | $40.3M | $34.2M | $26.0M | $22.2M | $13.7M | $10.9M | $8.8M | $4.1M | $3.4M | $3.6M | $2.6M | $2.7M | $2.3M | ||
| Additional Paid In Capital Common Stock | $228.2M | $199.1M | $156.8M | $142.1M | $117.5M | $45.4M | $40.6M | $38.5M | $36.5M | $34.3M | $33.1M | $30.3M | |||
| Liabilities Current | $41.8M | $35.6M | $27.3M | $22.7M | $14.3M | $14.8M | $43.4M | $4.1M | $4.1M | $3.6M | $2.8M | $14.3M | $18.2M | ||
| Marketable Securities Current | $349.7M | $484.2M | $489.4M | $534.8M | $376.1M | $132.0M | $116.6M | $51.6M | $23.2M | $47.1M | $12.0M | $11.3M | |||
| Accounts Receivable Net Current | $1.5M | $874.0K | $986.0K | $2.8M | $1.8M | $813.0K | $151.0K | $438.0K | $200.0K | $315.0K | $215.0K | $440.0K | |||
| Operating Lease Payments | $1.7M | $1.7M | $1.6M | $919.0K | $824.0K | $634.0K | $634.0K | $624.0K | |||||||
| Fair Value Of Stock Options Exercised On Cashless Basis | $8.3M | $5.3M | $4.5M | $3.3M | $887.0K | $719.0K | |||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | $56.5M | -$5.9M | $91.4M | -$118.4M | $130.7M | $20.3M | -$43.0M | $47.3M | |||||||
| Operating Lease Right Of Use Asset | $6.6M | $7.9M | $9.2M | $10.4M | $8.1M | $3.3M | $933.0K | ||||||||
| Operating Lease Liability Noncurrent | $6.4M | $7.6M | $9.6M | $9.9M | $7.7M | $3.1M | $743.0K | ||||||||
| Operating Lease Liability Current | $1.5M | $1.4M | $1.3M | $488.0K | $605.0K | $265.0K | $168.0K | ||||||||
| Cash And Cash Equivalents Period Increase Decrease | $47.3M | $3.4M | -$41.6M | -$13.4M | $34.1M | -$22.2M | $46.2M | ||||||||
| Preferred Stock Value | $7.7M | $7.7M | $7.7M | $7.7M | $102.5M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $559.5M | $634.0M | $704.0M | $797.8M | $844.0M | $887.7M | $636.6M | $646.5M | $686.9M | $753.1M | $785.8M | $541.9M | $248.9M | $257.0M | $276.3M | $182.0M | $189.3M | $188.0M | $74.6M | $82.8M | $92.3M | $111.2M | $50.6M | $28.5M | $43.3M | $50.5M | $57.2M | $69.3M | $52.7M | $58.2M | $64.5M | $64.3M | $69.0M | -$67.5M | ||||
| Cash And Cash Equivalents At Carrying Value | $104.5M | $135.4M | $116.7M | $87.6M | $136.7M | $58.9M | $99.6M | $64.6M | $69.5M | $103.5M | $370.0M | $116.5M | $87.8M | $82.9M | $88.0M | $15.1M | $44.2M | $37.7M | $37.1M | $52.2M | $88.0M | $47.4M | $17.2M | $20.5M | $14.7M | $23.1M | $20.2M | $54.1M | $35.2M | $56.1M | $65.5M | $64.3M | $65.9M | $33.7M | $35.1M | $34.9M | $43.6M | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations | $104.5M | $135.4M | $116.7M | $87.6M | $136.7M | $58.9M | $99.6M | $64.6M | $69.5M | $103.5M | $370.0M | $116.5M | $87.8M | $82.9M | $88.0M | $15.1M | $44.2M | $60.5M | $37.7M | $37.1M | $88.0M | |||||||||||||||||
| Retained Earnings Accumulated Deficit | -$1.14B | -$1.05B | -$964.5M | -$833.8M | -$771.0M | -$713.1M | -$620.4M | -$571.9M | -$524.5M | -$445.4M | -$408.2M | -$377.0M | -$331.8M | -$316.4M | -$294.3M | -$266.2M | -$257.3M | -$238.3M | -$229.4M | -$219.4M | -$199.3M | -$184.9M | -$177.1M | -$165.3M | -$157.6M | -$150.2M | -$136.7M | -$129.0M | -$123.0M | -$115.8M | -$111.8M | -$108.0M | -$105.0M | |||||
| Property Plant And Equipment Net | $8.9M | $9.2M | $9.7M | $10.2M | $10.1M | $9.4M | $10.2M | $9.6M | $8.0M | $4.6M | $4.5M | $4.3M | $4.3M | $4.3M | $3.7M | $3.0M | $2.3M | $1.2M | $1.3M | $1.2M | $962.0K | $1.1M | $1.1M | $1.2M | $1.3M | $1.4M | $1.5M | $1.7M | $1.8M | $2.1M | $2.2M | $2.4M | $2.0M | |||||
| Prepaid Expense And Other Assets Current | $17.1M | $11.6M | $7.3M | $4.7M | $5.7M | $6.8M | $3.5M | $2.9M | $4.1M | $8.5M | $4.0M | $4.8M | $3.5M | $3.3M | $3.5M | $2.3M | $2.5M | $1.7M | $1.4M | $1.5M | $2.2M | $909.0K | $1.2M | $1.1M | $739.0K | $925.0K | $1.3M | $2.0M | $1.8M | $371.0K | $465.0K | $464.0K | $171.0K | |||||
| Liabilities And Stockholders Equity | $607.8M | $674.3M | $743.3M | $835.9M | $884.0M | $919.0M | $671.1M | $684.9M | $719.9M | $775.8M | $807.4M | $558.1M | $264.4M | $274.7M | $290.7M | $199.1M | $210.7M | $98.9M | $105.9M | $114.6M | $130.5M | $65.4M | $37.8M | $46.4M | $54.2M | $60.8M | $73.4M | $55.7M | $61.2M | $69.9M | $76.5M | $79.4M | $54.1M | |||||
| Liabilities | $48.3M | $40.3M | $39.3M | $38.1M | $40.0M | $31.3M | $34.5M | $38.4M | $32.9M | $22.7M | $21.6M | $16.2M | $15.4M | $17.7M | $14.4M | $17.1M | $21.4M | $24.3M | $23.1M | $22.2M | $19.3M | $14.8M | $9.3M | $3.1M | $3.8M | $3.6M | $4.1M | $3.0M | $3.0M | $5.5M | $12.2M | $10.4M | $19.2M | |||||
| Common Stock Value | $1.48B | $1.47B | $1.46B | $1.44B | $1.44B | $1.44B | $1.12B | $1.08B | $1.07B | $1.06B | $1.06B | $800.3M | $504.4M | $499.4M | $498.3M | $397.7M | $397.7M | $266.4M | $266.1M | $266.0M | $261.7M | $177.0M | $147.9M | $173.8M | $173.8M | $173.8M | $172.9M | $148.9M | $148.7M | $148.4M | $147.8M | $147.5M | $6.2M | |||||
| Assets Current | $480.1M | $500.3M | $565.5M | $659.6M | $728.1M | $707.2M | $531.0M | $544.6M | $533.4M | $649.2M | $794.8M | $545.6M | $256.3M | $266.8M | $283.3M | $194.8M | $207.0M | $96.5M | $103.3M | $112.0M | $129.5M | $64.4M | $36.7M | $45.0M | $52.6M | $59.1M | $71.4M | $53.4M | $58.3M | $66.1M | $74.4M | $77.1M | $48.3M | |||||
| Assets | $607.8M | $674.3M | $743.3M | $835.9M | $884.0M | $919.0M | $671.1M | $684.9M | $719.9M | $775.8M | $807.4M | $558.1M | $264.4M | $274.7M | $290.7M | $199.1M | $210.7M | $98.9M | $105.9M | $114.6M | $130.5M | $65.4M | $37.8M | $46.4M | $54.2M | $60.8M | $73.4M | $55.7M | $61.2M | $69.9M | $76.5M | $79.4M | $54.1M | |||||
| Accumulated Other Comprehensive Income Loss Net Of Tax | $477.0K | $113.0K | -$836.0K | $1.3M | -$2.2M | -$1.8M | -$3.0M | -$3.3M | -$1.8M | -$3.0M | -$990.0K | -$990.0K | -$990.0K | -$990.0K | -$990.0K | -$990.0K | -$990.0K | -$990.0K | -$990.0K | -$990.0K | -$990.0K | -$990.0K | -$990.0K | -$990.0K | -$990.0K | -$990.0K | -$990.0K | -$990.0K | -$990.0K | -$990.0K | -$990.0K | -$990.0K | $1.0M | |||||
| Accounts Payable And Accrued Liabilities Current | $36.8M | $31.6M | $30.6M | $28.3M | $29.9M | $20.9M | $23.5M | $26.9M | $21.3M | $15.5M | $13.7M | $8.0M | $10.0M | $11.2M | $7.6M | $8.9M | $7.8M | $7.9M | $6.7M | $5.8M | $4.4M | $3.1M | $2.4M | $3.1M | $3.8M | $3.6M | $4.0M | $2.9M | $2.9M | $2.8M | $2.3M | $1.5M | $2.8M | |||||
| Additional Paid In Capital Common Stock | $223.8M | $213.9M | $208.5M | $188.4M | $176.8M | $163.6M | $138.0M | $138.7M | $140.1M | $136.7M | $133.3M | $119.6M | $69.6M | $67.3M | $65.5M | $43.8M | $42.2M | $39.7M | $39.4M | $38.9M | $37.9M | $37.7M | $36.9M | $35.8M | $35.2M | $34.6M | $34.1M | $33.8M | $33.4M | $32.8M | $29.3M | $30.5M | ||||||
| Liabilities Current | $38.3M | $33.0M | $32.0M | $29.7M | $31.3M | $22.2M | $24.7M | $28.2M | $22.5M | $15.5M | $13.7M | $8.0M | $12.9M | $15.0M | $11.5M | $16.9M | $21.1M | $11.7M | $9.3M | $6.4M | $4.4M | $3.1M | $3.8M | $4.0M | $2.9M | $2.9M | $5.3M | $12.0M | $10.3M | $16.3M | ||||||||
| Marketable Securities Current | $357.8M | $352.2M | $433.0M | $566.4M | $584.8M | $640.7M | $427.1M | $475.0M | $457.5M | $534.7M | $418.3M | $421.4M | $161.8M | $177.6M | $186.7M | $175.8M | $158.6M | $56.9M | $64.7M | $58.2M | $39.2M | $15.8M | $17.9M | $29.1M | $28.6M | $37.9M | $15.4M | $15.5M | $9.4M | $9.5M | $14.2M | |||||||
| Accounts Receivable Net Current | $938.0K | $853.0K | $833.0K | $805.0K | $2.1M | $2.2M | $2.5M | $2.5M | $2.9M | $3.2M | $2.9M | $5.1M | $1.6M | $1.8M | $209.0K | $171.0K | $132.0K | $180.0K | $171.0K | $432.0K | $129.0K | $198.0K | $189.0K | $595.0K | $658.0K | $386.0K | $274.0K | $188.0K | $1.2M | $162.0K | ||||||||
| Operating Lease Payments | $420.0K | $411.0K | $406.0K | $203.0K | $202.0K | $159.0K | $158.0K | $152.0K | ||||||||||||||||||||||||||||||
| Fair Value Of Stock Options Exercised On Cashless Basis | $2.1M | $2.6M | $635.0K | $1.5M | $448.0K | $583.0K | $7.0K | $176.0K | $19.0K | |||||||||||||||||||||||||||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$26.1M | -$89.7M | $12.3M | -$59.1M | $43.0M | $35.8M | ||||||||||||||||||||||||||||||||
| Operating Lease Right Of Use Asset | $7.0M | $7.3M | $7.6M | $8.3M | $8.6M | $8.9M | $9.5M | $9.8M | $10.1M | $7.6M | $7.7M | $7.9M | $3.0M | $3.1M | $3.2M | $886.0K | $1.0M | $1.0M | $1.1M | $1.2M | ||||||||||||||||||
| Operating Lease Liability Noncurrent | $6.8M | $7.3M | $7.3M | $8.4M | $8.7M | $9.1M | $9.8M | $10.3M | $10.4M | $7.2M | $7.9M | $8.2M | $2.6M | $2.7M | $2.9M | $188.0K | $323.0K | $857.0K | $573.0K | $722.0K | ||||||||||||||||||
| Operating Lease Liability Current | $1.5M | $1.5M | $1.4M | $1.4M | $1.4M | $1.3M | $1.2M | $1.2M | $1.2M | $0.00 | $0.00 | $0.00 | $686.0K | $759.0K | $270.0K | $596.0K | $594.0K | $158.0K | $587.0K | $582.0K | ||||||||||||||||||
| Cash And Cash Equivalents Period Increase Decrease | -$15.6M | -$3.3M | $3.1M | -$2.6M | -$6.1M | -$3.0M | ||||||||||||||||||||||||||||||||
| Preferred Stock Value | $0.00 | $0.00 | $0.00 | $7.7M | $7.7M | $7.7M | $7.7M | $7.7M | $7.7M | $7.7M | $7.7M | $11.9M | $21.8M | $21.8M | $102.5M |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $117.1M | $12.1M | $353.5M | $278.5M | $447.5M | $85.8M | $27.5M | $111.6M | $7.1M | $24.0M | $278.0K | $41.1M | -$4.4M | |
| Investing Cash Flow * | $218.0M | $165.0M | -$111.4M | -$293.4M | -$246.8M | -$16.8M | -$66.2M | -$29.0M | $24.3M | -$47.8M | $10.2M | -$3.2M | -$11.5M | $491.0K |
| Operating Cash Flow * | -$279.1M | -$181.4M | -$151.1M | -$101.0M | -$69.5M | -$48.1M | -$4.7M | -$34.7M | -$28.7M | -$19.6M | -$18.1M | $266.0K | -$3.3M | $45.6M |
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $53.7M | $50.7M | $32.4M | $20.4M | $10.0M | $5.7M | $2.9M | $2.7M | $2.5M | $2.2M | $2.1M | $760.0K | $575.0K | $406.0K |
| Share Based Compensation | $53.7M | $50.7M | $32.4M | $20.4M | $10.0M | $5.7M | $2.9M | $2.6M | $2.2M | $2.2M | $3.7M | $760.0K | $575.0K | $406.0K |
| Payments To Acquire Property Plant And Equipment | $799.0K | $3.1M | $5.6M | $2.9M | $2.1M | $2.6M | $1.2M | $507.0K | $315.0K | $279.0K | $551.0K | $1.5M | $156.0K | $526.0K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $3.2M | $984.0K | -$1.6M | $10.5M | $1.5M | $269.0K | $820.0K | $928.0K | -$613.0K | -$571.0K | $1.2M | $573.0K | $14.0K | -$162.0K |
| Increase Decrease In Accounts Payable And Accrued Liabilities | $5.5M | $8.5M | $3.9M | $8.1M | $3.0M | $2.0M | $4.5M | $783.0K | -$3.0K | $484.0K | $17.0K | $518.0K | -$228.0K | $540.0K |
| Proceeds From Sale And Maturity Of Marketable Securities | $574.5M | $700.3M | $688.1M | $260.6M | $144.8M | $214.7M | $75.5M | $48.5M | $52.6M | $10.7M | $13.5M | $6.6M | $1.0M | |
| Increase Decrease In Accounts Receivable | $614.0K | -$130.0K | -$1.8M | $459.0K | $1.0M | $653.0K | -$280.0K | $232.0K | -$121.0K | $107.0K | -$209.0K | $76.0K | -$11.2M | |
| Payments To Acquire Marketable Securities | $355.7M | $532.3M | $793.9M | $551.1M | $389.5M | $228.9M | $140.5M | $77.0M | $28.0M | $47.6M | $15.3M | $17.9M | ||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 35.0K | 705.0K | 260.0K | 82.0K | 122.0K | 288.0K | 177.0K | 132.0K | 278.0K | 13.0K | ||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $458.0K | -$1.7M | $376.0K | -$2.5M | -$592.0K | -$593.0K | $406.0K | -$612.0K | ||||||
| Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations | -$612.0K | $753.0K | $1.9M | -$5.7M | -$4.1M | -$3.0M | $170.0K | |||||||
| Proceeds From Issuance Of Common Stock | $102.5M | $27.4M | $102.9M | $23.8M | $278.0K | $42.6M | $49.0K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q1 2017 | Q1 2016 | Q1 2015 | Q1 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financing Cash Flow * | $1.2M | $0.00 | $7.9M | $118.7M | $102.5M | $58.0K | $119.0K | $174.0K | $44.0K | $127.0K | -$393.0K | |||||||||||||||||
| Investing Cash Flow * | $34.5M | -$43.2M | $46.6M | -$48.9M | -$55.1M | -$52.9M | -$7.0M | $5.0M | $9.2M | -$83.0K | $1.5M | -$338.0K | ||||||||||||||||
| Operating Cash Flow * | -$61.7M | -$46.2M | -$34.4M | -$18.4M | -$20.7M | -$13.1M | -$8.7M | -$8.2M | -$6.5M | -$4.9M | -$5.5M | -$842.0K | ||||||||||||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $13.7M | $13.7M | $12.2M | $13.0M | $14.7M | $9.4M | $8.7M | $8.5M | $6.0M | $5.7M | $5.2M | $3.6M | $2.6M | $2.7M | $2.0M | $1.6M | $1.5M | $1.0M | $630.0K | $470.0K | $476.0K | $662.0K | $657.0K | $670.0K | $637.0K | $634.0K | $288.0K | |
| Share Based Compensation | $13.7M | $13.7M | $12.2M | $13.0M | $14.7M | $9.4M | $6.0M | $3.6M | $2.0M | $1.0M | $491.0K | $663.0K | $478.0K | $592.0K | $5.2M | $186.0K | ||||||||||||
| Payments To Acquire Property Plant And Equipment | $43.0K | $188.0K | $2.2M | $212.0K | $404.0K | $647.0K | $335.0K | $181.0K | $137.0K | $83.0K | $84.0K | $480.0K | ||||||||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $926.0K | $673.0K | -$2.9M | $272.0K | $533.0K | -$113.0K | -$389.0K | $435.0K | -$404.0K | -$82.0K | -$220.0K | -$29.0K | ||||||||||||||||
| Increase Decrease In Accounts Payable And Accrued Liabilities | -$3.8M | -$5.0M | -$594.0K | -$5.8M | -$3.2M | -$577.0K | $1.6M | -$1.0M | $186.0K | -$160.0K | -$1.1M | -$265.0K | ||||||||||||||||
| Proceeds From Sale And Maturity Of Marketable Securities | $165.8M | $133.8M | $157.1M | $20.3M | $46.0M | $55.2M | $27.6M | $13.3M | $9.4M | $1.6M | $2.7M | |||||||||||||||||
| Increase Decrease In Accounts Receivable | -$38.0K | -$226.0K | $155.0K | $3.2M | $824.0K | -$20.0K | -$40.0K | -$11.0K | $60.0K | $996.0K | -$2.0K | |||||||||||||||||
| Payments To Acquire Marketable Securities | $131.2M | $176.8M | $108.3M | $69.0M | $100.7M | $107.5M | $34.3M | $8.1M | $2.6M | |||||||||||||||||||
| Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options | 106.0K | 14.0K | 58.0K | 119.0K | 174.0K | 44.0K | ||||||||||||||||||||||
| Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | -$64.0K | -$367.0K | $59.0K | $293.0K | $67.0K | -$725.0K | ||||||||||||||||||||||
| Effect Of Exchange Rate On Cash And Cash Equivalents Continuing Operations | $67.0K | -$163.0K | $104.0K | $2.4M | -$2.2M | -$1.4M | ||||||||||||||||||||||
| Proceeds From Issuance Of Common Stock | $7.9M | $44.0K | $127.0K | $5.0K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$4.36 | -$3.01 | -$2.73 | -$2.06 | -$1.77 | -$0.81 | -$1.54 | -$1.63 | -$1.72 | -$1.48 | -$1.10 | $3.28 | $1.91 | -$3.24 |
| Earnings Per Share Basic | $-4.36 | $-3.01 | $-2.73 | $-2.06 | $-1.77 | $-0.81 | $-1.63 | $-1.71 | $-1.48 | $-1.10 | $4.11 | $2.87 | $-3.24 | |
| Weighted Average Number Of Shares Outstanding Basic | 79.3M | 77.9M | 66.9M | 60.5M | 43.6M | 34.5M | 19.4M | 18.0M | 15.5M | 14.3M | 3.2M | 1.3M | 1.3M | |
| Weighted Average Number Of Diluted Shares Outstanding | 79.3M | 77.9M | 66.9M | 60.5M | 43.6M | 34.5M | 19.4M | 18.0M | 15.5M | 14.3M | 4.0M | 2.0M | 1.3M | |
| Common Stock Shares Outstanding | 80.0M | 76.4M | 75.4M | 62.6M | 51.6M | 35.0M | 28.1M | 25.8M | 18.0M | 17.9M | 14.4M | 14.2M | 1.3M | |
| Common Stock Shares Issued | 80.0M | 76.4M | 75.4M | 62.6M | 51.6M | 35.0M | 28.1M | 25.8M | 18.0M | 17.9M | 14.4M | 14.2M | 1.3M | |
| Preferred Stock Shares Outstanding | 0.00 | 1.0M | 1.0M | 1.0M | 1.0M | 0.00 | ||||||||
| Preferred Stock Shares Issued | 0.00 | 1.0M | 1.0M | 1.0M | 1.0M | |||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 43.6M | 34.5M | 25.9M | 19.4M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q4 2017 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q4 2015 | Q3 2015 | Q2 2015 | Q1 2015 | Q4 2014 | Q3 2014 | Q2 2014 | Q1 2014 | Q4 2013 | Q3 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$1.15 | -$1.07 | -$0.83 | -$0.81 | -$0.75 | -$0.62 | -$0.73 | -$0.72 | -$0.63 | -$0.57 | -$0.55 | -$0.35 | -$0.36 | -$0.51 | -$0.42 | -$0.25 | $0.00 | -$0.22 | -$0.33 | -$0.37 | -$0.42 | -$0.63 | -$0.45 | -$0.21 | -$0.45 | -$0.43 | -$0.41 | -$0.43 | -$0.51 | -$0.42 | -$0.23 | -$0.27 | -$0.27 | -$0.07 | -$0.64 | $0.13 | $1.69 | $1.17 | $0.63 | ||
| Earnings Per Share Basic | $-1.15 | $-1.07 | $-0.83 | $-0.81 | $-0.75 | $-0.62 | $-0.73 | $-0.72 | $-0.63 | $-0.57 | $-0.55 | $-0.35 | $-0.36 | $-0.51 | $-0.42 | $-0.63 | $-0.45 | $-0.21 | $-0.45 | $-0.43 | $-0.41 | $-0.42 | $-0.51 | $-0.42 | $-0.23 | $-0.27 | $-0.27 | $0.08 | $-0.64 | $0.14 | $2.67 | $1.87 | $0.99 | ||||||||
| Weighted Average Number Of Shares Outstanding Basic | 79.2M | 79.0M | 78.7M | 77.9M | 77.7M | 77.6M | 66.0M | 65.9M | 65.7M | 65.5M | 56.2M | 54.9M | 42.3M | 42.1M | 35.0M | 25.8M | 25.8M | 20.3M | 14.3M | 17.8M | 18.0M | 18.0M | 17.9M | 15.3M | 14.4M | 14.4M | 14.3M | 14.2M | 1.3M | 1.3M | 1.3M | ||||||||||
| Weighted Average Number Of Diluted Shares Outstanding | 79.2M | 79.0M | 78.7M | 77.9M | 77.7M | 77.6M | 66.0M | 65.9M | 65.7M | 65.5M | 56.2M | 54.9M | 42.3M | 42.1M | 35.0M | 25.8M | 25.8M | 20.3M | 14.3M | 17.8M | 18.0M | 18.0M | 18.0M | 15.3M | 14.4M | 14.4M | 14.3M | 15.1M | 2.1M | 1.3M | 2.1M | ||||||||||
| Common Stock Shares Outstanding | 77.1M | 76.9M | 76.6M | 75.8M | 75.7M | 75.5M | 65.0M | 63.7M | 63.1M | 62.5M | 62.2M | 53.1M | 41.4M | 41.1M | 41.0M | 35.0M | 35.0M | 25.9M | 25.8M | 25.8M | 25.2M | 17.6M | 14.2M | 18.0M | 18.0M | 18.0M | 17.9M | 14.4M | 14.4M | 14.3M | 14.3M | 14.2M | 1.3M | ||||||||
| Common Stock Shares Issued | 77.1M | 76.9M | 76.6M | 75.8M | 75.7M | 75.5M | 65.0M | 63.7M | 63.1M | 62.5M | 62.2M | 53.1M | 41.4M | 41.1M | 41.0M | 35.0M | 35.0M | 25.9M | 25.8M | 25.8M | 25.2M | 17.6M | 14.2M | 18.0M | 18.0M | 18.0M | 17.9M | 14.4M | 14.4M | 14.3M | 14.3M | 14.2M | 1.3M | ||||||||
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.6M | 2.9M | 2.9M | 0.00 | ||||||||||||||||||||||||||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.0M | 1.6M | 2.9M | 2.9M | 0.00 | ||||||||||||||||||||||||||
| Weighted Average Number Of Share Outstanding Basic And Diluted | 54.9M | 41.2M | 43.1M | 36.8M | 35.0M | 35.0M | 33.2M | 25.8M | 20.3M | 15.3M | 14.4M | 14.3M | 14.2M | 1.3M |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $26.8M | $41.9M | $27.6M | $8.7M | $466.0K | $2.3M | $2.4M | $1.2M | $477.0K | $504.0K | $542.0K | $568.0K | $338.0K | $144.0K |
| Foreign Currency Transaction Gain Loss Before Tax | $1.3M | -$1.1M | $199.0K | -$1.9M | $358.0K | $1.4M | $282.0K | -$701.0K | $1.4M | $1.3M | -$6.9M | $1.3M | $2.0M | -$169.0K |
| Stock Issued During Period Shares Stock Options Exercised | 1.0M | 587.5K | 780.7K | 690.3K | 171.8K | 266.2K | 251.2K | 71.0K | 121.3K | 270.3K | 2.4K | 8.3K | ||
| Foreign Currency Transaction Gain Loss Unrealized | -$73.0K | -$745.0K | $640.0K | -$2.7M | -$327.0K | $434.0K | $302.0K | -$646.0K | $1.5M | $1.3M | -$6.9M | -$72.0K | -$94.0K | $34.0K |
| Depreciation And Amortization | $2.5M | $2.6M | $2.1M | $1.4M | $906.0K | $644.0K | $429.0K | $586.0K | $649.0K | $864.0K | $1.0M | $738.0K | $705.0K | $786.0K |
| Stock Issued During Period Value Stock Options Exercised | $47.0K | $35.0K | $705.0K | $260.0K | $82.0K | $122.0K | $177.0K | $132.0K | $278.0K | $13.0K | $49.0K | |||
| Stock Issued During Period Value New Issues | $112.2M | $12.1M | $353.5M | $277.8M | $447.3M | $102.5M | $27.4M | $102.9M | $23.8M | $38.4M | ||||
| Interest Income Deposits With Financial Institutions | $3.5M | $4.1M | $2.2M | $1.1M | $740.0K | $341.0K | $659.0K | $574.0K | $279.0K | |||||
| Prepaid Expense Noncurrent | $7.2M | $7.5M | $7.4M | $7.8M | $0.00 | $230.0K | $408.0K | $1.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 | Q3 2019 | Q2 2019 | Q1 2019 | Q3 2018 | Q2 2018 | Q1 2018 | Q3 2017 | Q2 2017 | Q1 2017 | Q3 2016 | Q2 2016 | Q1 2016 | Q3 2015 | Q2 2015 | Q1 2015 | Q3 2014 | Q2 2014 | Q1 2014 | Q3 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Investment Income Interest | $6.2M | $7.2M | $8.1M | $10.3M | $10.8M | $11.4M | $7.0M | $6.5M | $5.4M | $3.1M | $816.0K | $368.0K | $57.0K | $72.0K | $146.0K | $166.0K | $912.0K | $1.1M | $528.0K | $706.0K | $682.0K | $325.0K | $125.0K | $108.0K | $124.0K | $109.0K | $149.0K | $114.0K | $123.0K | $99.0K | $130.0K | $163.0K | $152.0K | $138.0K | $137.0K | $141.0K | $117.0K |
| Foreign Currency Transaction Gain Loss Before Tax | -$89.0K | $1.7M | $35.0K | $237.0K | $10.0K | $167.0K | -$407.0K | $383.0K | $313.0K | -$2.4M | -$411.0K | $299.0K | -$128.0K | $117.0K | $155.0K | $475.0K | $662.0K | -$238.0K | -$80.0K | $135.0K | $130.0K | $148.0K | -$140.0K | -$284.0K | $778.0K | $404.0K | $321.0K | -$497.0K | $227.0K | $2.3M | -$3.1M | $806.0K | -$3.2M | $392.0K | -$285.0K | $200.0K | -$243.0K |
| Stock Issued During Period Shares Stock Options Exercised | 180.4K | 6.4K | 278.1K | 113.7K | 369.3K | 130.0K | 219.1K | 42.0K | 222.3K | 122.4K | 375.00 | 54.7K | 98.3K | 148.9K | 3.5K | 22.4K | 119.1K | 34.1K | 84.7K | 3.1K | 67.9K | 42.0K | 14.3K | 16.2K | 110.0K | 55.2K | 44.7K | 1.0K | 772.00 | 3.1K | |||||||
| Foreign Currency Transaction Gain Loss Unrealized | -$182.0K | -$4.0K | $5.0K | $142.0K | $204.0K | -$522.0K | $23.0K | -$267.0K | $326.0K | $2.3M | -$3.1M | -$37.0K | |||||||||||||||||||||||||
| Depreciation And Amortization | $659.0K | $586.0K | $354.0K | $376.0K | $196.0K | $104.0K | $79.0K | $150.0K | $165.0K | $282.0K | $207.0K | $175.0K | |||||||||||||||||||||||||
| Stock Issued During Period Value Stock Options Exercised | $699.0K | $28.0K | $111.0K | $106.0K | $23.0K | $14.0K | $18.0K | $11.0K | $58.0K | $80.0K | $63.0K | $119.0K | $174.0K | $44.0K | $127.0K | ||||||||||||||||||||||
| Stock Issued During Period Value New Issues | $2.4M | $65.0K | $1.2M | $29.5M | $269.9M | $7.9M | $4.7M | $118.6M | $102.5M | $73.9M | $29.0M | ||||||||||||||||||||||||||
| Interest Income Deposits With Financial Institutions | $651.0K | $1.2M | $709.0K | $141.0K | $55.0K | $112.0K | $121.0K | ||||||||||||||||||||||||||||||
| Prepaid Expense Noncurrent | $7.1M | $9.2M | $8.1M | $7.5M | $7.4M | $7.3M | $7.3M | $7.9M | $8.0M | $218.0K | $285.0K | $269.0K | $479.0K | $632.0K | $1.1M | $1.7M |
Most recent annual filing with the SEC: February 26, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.